In the BioHarmony Drug Report Database

"Preview" Icon

Perampanel

Fycompa (perampanel) is a small molecule pharmaceutical. Perampanel was first approved as Fycompa on 2012-07-23. It is used to treat partial epilepsies, seizures, and tonic-clonic epilepsy in the USA. It has been approved in Europe to treat partial epilepsies. Fycompa’s patents are valid until 2026-07-01 (FDA).

 

Trade Name

 

Fycompa
 

Common Name

 

perampanel
 

ChEMBL ID

 

CHEMBL1214124
 

Indication

 

partial epilepsies, seizures, tonic-clonic epilepsy
 

Drug Class

 

Ionotropic non-NMDA glutamate receptors (AMPA and/or KA receptors): antagonists

Image (chem structure or protein)

Perampanel structure rendering